Top Mover

Morgan Stanley Upgrades Lockheed Martin to Buy With $835 Target After F-35 Framework Deal and Record $292B Backlog

Read this in the Market Flux app

Lockheed Martin Corporation $LMT

$635.40+5.12%as of publication

5D Change
+15.85%
Market Cap
$139.57B

Morgan Stanley upgraded Lockheed Martin to Overweight from Equal-weight on Monday and raised its price target to $835 from $690, implying roughly 38% upside from Friday's close, citing a newly announced 10-year framework agreement between Lockheed and the U.S. Department of Defense to produce and support at least 850 F-35 Lightning II stealth fighters at an annual rate of 156 aircraft. Analyst Kristine Liwag said the deal removes a key overhang: investors had feared the F-35 program, which accounts for 20% to 30% of Lockheed's revenue, could be cut to fund missile expansion. Liwag said the announcement "effectively removes this risk from the stock" and supports the F-35's role in U.S. and allied air dominance.

Bank of America also raised its price target on the stock, to $620 from $600, citing a strong outlook, though the firm flagged potential cash flow risks. Jefferies separately lifted its target to $615 from $595. The upgrades and target increases follow Lockheed's strong third-quarter 2026 results, which included a record $292 billion backlog. Key segments, including Aeronautics and Missiles and Fire Control, posted significant profit growth in the first nine months of the year, with mid-teens growth in the Missiles and Fire Control unit.

Shares of Lockheed rose sharply on the news, with the stock up roughly 9.6% following its earnings beat before additional gains on Monday's analyst action. The moves put several defense-focused ETFs with significant Lockheed exposure in focus as well. Lockheed also featured in CNBC's "Halftime Report Final Trades" session, reflecting the stock's broad prominence across Wall Street commentary for the day.

© AI-generated summary is provided by Market Flux

Sources

  1. CnbcLockheed Martin will surge nearly 40% after new Pentagon deal, says Morgan Stanley
  2. Seeking AlphaLockheed Martin gains as Morgan Stanley upgrades stock on F-35 deal
  3. BarronsLockheed Stock Has 40% Upside, Analyst Says. Is the Worst Over for Defense?
  4. Yahoo FinanceGlobal Counter-Drone Defense Systems Market Report 2026 | Capitalize on 21.1% CAGR Through 2030 as RTX, Lockheed Martin, Airbus, Anduril, and DroneShield Accelerate AI Defense
  5. InvestingBofA raises Lockheed Martin stock price target on strong outlook
  6. NasdaqETFs to Buy as Lockheed Shares Jump Post Q3 Earnings Beat, Record Backlog
  7. 247 WallstHere Are Monday’s Top Wall Street Analyst Research Calls: Block, Boise Cascade, Equifax, FirstEnergy, Lockheed Martin, Lumentum Holdings, NetApp, Roper Technologies, Spotify, Technology, and More
  8. BenzingaIBM, Lockheed Martin, Goldman Sachs And An Energy Stock On CNBC's ‘Final Trades'
Show 5 more
  1. ZerohedgePremarket movers: Mag 7 stocks are mostly higher: Meta Platforms (META) up +2.4% after announcing sale of up to $95 billion in common and preferred stock; Tesla (TSLA) gains 1.8% as Barclays upgrades to overweight from equal-weight, citing M&A opportunity with SpaceX; Alphabet (GOOGL) +0.5%, Amazon (AMZN) +0.2%, Microsoft (MSFT) +0.4%, Nvidia (NVDA) +0.4%, Apple (AAPL) -1.7%. US-listed shares of Brazilian companies, and those exposed to the country, slump after President Luiz Inácio Lula da Silva surprised the markets to come from behind to win a runoff election. Among movers: PagSeguro (PAGS) -32%, NU Holdings (NU) -25%, MercadoLibre (MELI) -14% ArriVent Biopharma (AVBP) is trading higher by 4.5% after early-stage data for the company’s ARR-217 product candidate was presented at ESMO, a key cancer conference. Booz Allen Hamilton Holding Corp. (BAH) rises 0.9% as it is being upgraded to buy from hold at TD Cowen, which writes that shares of the IT services company look attractively valued in the wake of long-term share-price weakness. Borr Drilling shares (BORR) drop 8.2% after the company said search and rescue operations are ongoing for five individuals who remain unaccounted for after its Prospector 5 drilling rig sank during jacking operations offshore Gabon on Oct. 24. Coinbase Global Inc. shares (COIN) are down 1.7% as Bernstein cut its price target on the exchange to $250 from $330 on lower expected crypto volumes. Equifax Inc. (EFX) falls 3.5% after it was cut to sector perform from outperform with RBC saying the the recent stock rally “off the lows has left risk/reward more balanced” given concerns on higher rates, regulatory overhand and consumer lending pressure. Fair Isaac Corp. (FICO) falls 9.2% after it was cut to equal-weight from overweight at Wells Fargo, citing its lower-than-expected 2027 pricing announcement. FirstEnergy Corp. shares (FE) rise 0.5% after BMO Capital Markets initiated coverage of the utilities company with a recommendation of outperform as it sees an attractive valuation. Lockheed Martin Corp. shares (LMT) are up 1.4% after Morgan Stanley upgraded the defense company to overweight from equal-weight, writing that a recent deal for F-35 fighter jets “takes significant risk out of the stock.” Moderna (MRNA) slumps 8.2%, set to extend their decline for a third session, after the drugmaker gave results from a trial of its experimental vaccine used in the treatment of pancreatic cancer. Nutanix Inc. shares (NTNX) are up 5.3% after Guggenheim Securities started coverage on the infrastructure software company with a buy rating and $100 price target, seeing an ability for it to take market share. Range Resources (RRC) rises 8.9% after EQT (EQT -8.1%) agreed to buy the energy firm in an all-stock transaction to create a combined natural gas company with a pro forma enterprise value over $50 billion. Spotify Technology SA shares (SPOT) are down 1.4% after Phillip Securities downgraded the audio-streaming company to accumulate from buy, a move that comes in the wake of its recent results. Xencor (XNCR) climbs 31% after the drug developer gave updated results from an early-stage trial of its experimental drug for kidney cancer that impressed Wall Street.
  2. Marketsday#Analyst Ratings Changes – October 26, 2026 🔹 Upgrades 🔹 Inspired Entertainment $INSE upgraded to Outperform from Neutral at Macquarie with a $7 price target. 🔹 Kaiser Aluminum $KALU upgraded to Neutral from Underweight at JP Morgan with a $140 price target. 🔹 LKQ $LKQ upgraded to Overweight from Equal Weight at Barclays with a $25 price target. 🔹 Lockheed Martin $LMT upgraded to Overweight from Equal-Weight at Morgan Stanley with a $835 price target. 🔹 NorthWestern $NWE upgraded to Overweight from Equal Weight at Wells Fargo with a $90 price target. 🔹 Precision Drilling $PDS upgraded to Outperform from Sector Perform at National Bank Financial. 🔹 Roper Technologies $ROP upgraded to Neutral from Underweight at JP Morgan with a $490 price target. 🔹 Ross Stores $ROST upgraded to Buy from Neutral at UBS with a $315 price target. 🔹 Safehold $SAFE upgraded to Equal-Weight from Underweight at Morgan Stanley with a $12 price target.
  3. OpenOutcrierUpgrades 10/26: $BAH $BTU $CACI $CNOB $EFSC $GMAB $INTC $KALU $LKQ $LMT $NOA $NWE $ROP $ROST $SAFE $SOTK $TSLA . Downgrades 10/26: $AAP $ARCO $BCC $BLDR $CATX $CRS $E $EFX $FCNCA $FICO $FND $LKQ $RHP $SE $SHO $SPOT $TEF $USCB $XYZ
  4. BarronsonlineMorgan Stanley analyst Kristine Liwag upgraded Lockheed Martin shares to Buy from Hold and raised her price target to $835.
  5. TheflynewsTrump Trade: U.S. to remove 50% tariffs on certain Canadian products $CF $CMP $ANDE $ADM $BG $IPI $MOS $WFG $LPX $UFPI $BCC $LMT $CACI